Protocol: Carboplatin/Gemcitabine

Protocol: ABVD - Mid-Western Cancer Centre

Department of Medical Oncology Chemotherapy Protocols 3rd Edition 84 Protocol: ABVD Indications: Hodgkin’s disease Schedule:

  Indications, Abvd, Abvd indications

Protocol: Doxorubicin/Cisplatin - Mid-Western …

Department of Medical Oncology Chemotherapy Protocols 3rd Edition 78 Protocol: Doxorubicin/Cisplatin Indications: Osteosarcoma - neoadjuvant

  Protocol, Doxorubicin, Cisplatin, Doxorubicin cisplatin

Protocol: PCV (Procarbazine/CCNU/Vincristine)

Department of Medical Oncology Chemotherapy Protocols 3rd Edition 100 Protocol: PCV (Procarbazine/CCNU/Vincristine) Indication: Brain Tumours – Palliative

  Protocol, Tumours, Vincristine, Procarbazine ccnu vincristine, Procarbazine, Ccnu

Protocol: BEP 3-day (Bleomycin/Etoposide/Cisplatin)

Department of Medical Oncology Chemotherapy Protocols 3rd Edition 64 Protocol: Carboplatin Indications: Seminoma – stage 1 adjuvant

  Cisplatin, Bleomycin, Etoposide, 3 day, Bleomycin etoposide cisplatin, Seminoma

Protocol: AC (Doxorubicin/Cyclophosphamide)

Department of Medical Oncology Chemotherapy Protocols 3rd Edition 19 Protocol: Paclitaxel Indications: Breast Cancer – Adjuvant (high risk), Palliative

  Protocol, Doxorubicin, Palliative, Cyclophosphamide, Doxorubicin cyclophosphamide

Department of Medical Oncology Chemotherapy …

Department of Medical Oncology Chemotherapy Protocols 3rd Edition 113 Mesna Dose Guidelines (RKG/OF/MK – December 05)

  Department, Medical, Protocol, Oncology, Chemotherapy, Department of medical oncology chemotherapy, Department of medical oncology chemotherapy protocols

Protocol: CF (Cisplatin/5-Fluorouracil)

Department of Medical Oncology Chemotherapy Protocols 3rd Edition 103 Protocol: CF (Cisplatin/5-Fluorouracil) Indications: Head and neck – metastatic, recurrent

  Protocol, Cisplatin, Fluorouracil, Cisplatin 5 fluorouracil

Protocol: Carboplatin/Paclitaxel - Mid-Western …

Department of Medical Oncology Chemotherapy Protocols 3rd Edition 57 Protocol: Carboplatin Indications: Ovarian Cancer – Advanced, Recurrent

  Protocol, Indications, Carboplatin, Paclitaxel, Carboplatin paclitaxel

DRUG NAME: Carboplatin

Carboplatin DRUG NAME: Carboplatin SYNONYM(S): CBDCA, JM8, NSC 241240 COMMON TRADE NAME(S): PARAPLATIN®, PARAPLATIN-AQ® CLASSIFICATION: Alkylating agent Special pediatric considerations are noted when applicable, otherwise adult provisions apply.

  Name, Drug, Drug name, Carboplatin

Gem-Cisp: Gemcitabine/Cisplatin in Relapsed …

Reason for Update: Network Protocol Development Gemcitabine. should be used with caution in patients with impaired renal function: CrCl (ml/min) Gemcitabine Dose

2 QUALITATIVE AND QUANTITATIVE COMPOSITION

New Zealand Data Sheet 16 October 2017 Lasix and Lasix High Dose- furosemide (frusemide) lasix-lasix-high-dose-ccdsv12-dsv15-16oct17 Page 1

Protocol: BEP 3-day (Bleomycin/Etoposide/Cisplatin)

Department of Medical Oncology Chemotherapy Protocols 3rd Edition 62 Protocol: BEP 3-day (Bleomycin/Etoposide/Cisplatin) ...

  Cisplatin, Bleomycin, Etoposide, 3 day, Bleomycin etoposide cisplatin

LESSON ASSIGNMENT LESSON 6 Drugs Used to …

MD0913 6-3 c. Cautions and Warnings. (1) This drug should be used cautiously in pregnant women because of the fact that it can cross the placenta and cause ototoxicity (see d (1) below) in the fetus.

  Drug, Used, Lesson, Assignment, Lesson assignment lesson 6 drugs used, Ototoxicity

GENETIS LAORATORY TEST REQUEST FORM - …

Shodair hildren’s Hospital Genetics Laboratory 2755 olonial Dr, Helena. MT, 59601 Phone (406) 444-7532 Toll Free (800) 447-6614 Fax (406) 444-1022 email: mtgene@shodair.org

HIGHLIGHTS OF PRESCRIBING INFORMATION …

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use TOBI Podhaler safely and effectively. See full prescribing information for TOBI

  Information, Prescribing, Prescribing information